Community-Acquired Pneumonia

This book will be published in September 2027. It will be available to pre-order in July 2027.

Edited by Mathias W. Pletz, Catia Cilloniz and Markus Fally

Contents list (subject to change)
1. Community-acquired pneumonia: defining the disease, setting the scene, and global burden
2. Bacterial pathogens in CAP
3. Clinical implications for prevention and future perspectives: viral pneumonia: epidemiology, diagnosis and management
4. Microbiome and lung ecology in community-acquired peumonia: host–pathogen–environment interactions and clinical relevance
5. Decoding the host response: from lung infection to systemic inflammation
6. Diagnosis of community-acquired pneumonia: from clinical assessment to imaging and molecular tools
7. Precision risk stratification in CAP: who will deteriorate?
8. Anti-infective treatment: antibiotics and antivirals
9. Antimicrobial resistance and stewardship in CAP
10. Adjuvant treatment in community-acquired pneumonia: current evidence and emerging immunomodulatory strategies
11. Complications and long-term sequelae of CAP
12. Severe pneumonia and pneumogenic sepsis and mechanical ventilation
13. CAP care pathways: community management, hospital admission, and hospital-at-home models
14. Pulmonary rehabilitation, early mobilisation and physiotherapy in CAP
15. Vaccination for CAP: pneumococcal influenza, RSV and beyond
16. CAP in the immunocompromised
17. Community-acquired pneumonia in children: challenges and opportunities
18. Community-acquired pneumonia in the elderly: challenges in diagnosis and management
19. Case-based learning and interactive decision pathways in community-acquired pneumonia: from presentation to recovery
20. Unmet needs in community-acquired pneumonia: patient experience, outcomes, and clinical trial innovation

Print ISBN: 978-1-84984-226-6
eISBN: 978-1-84984-227-3
EPUB ISBN: 978-1-84984-228-0